Commentary: resolving pertussis resurgence and vaccine immunity using mathematical transmission models.
Pertussis epidemiology
mathematical modeling
pertussis resurgence
pertussis vaccines
statistical inference
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
2019
2019
Historique:
pubmed:
21
11
2018
medline:
27
2
2020
entrez:
21
11
2018
Statut:
ppublish
Résumé
The epidemiology of pertussis-a vaccine-preventable respiratory infection typically caused by the bacterium Bordetella pertussis-remains puzzling. Indeed, the disease seems nowhere close to eradication and has even re-emerged in certain countries-such as the US-that have maintained high vaccination coverage. Because the dynamics of pertussis are shaped by past vaccination and natural infection rates, with the relevant timescale spanning decades, the interpretation of such unexpected trends is not straightforward. In this commentary, we propose that mathematical transmission models play an essential role in helping to interpret the data and in closing knowledge gaps in pertussis epidemiology. We submit that recent advances in statistical inference methods now allow us to estimate key parameters, such as the nature and duration of vaccinal immunity, which have to date been difficult to quantify. We illustrate these points with the results of a recent study based on data from Massachusetts (Domenech de Cellès, Magpantay, King, and Rohani, Sci. Transl. Med. 2018;10: eaaj1748. doi:10.1126/scitranslmed.aaj1748), in which we used such methods to elucidate the mechanisms underlying the ongoing resurgence of pertussis. In addition, we list a number of safety checks that can be used to critically assess mathematical models. Finally, we discuss the remaining uncertainties surrounding pertussis vaccines, in particular the acellular vaccines used for teenage booster immunizations.
Identifiants
pubmed: 30457424
doi: 10.1080/21645515.2018.1549432
pmc: PMC6988877
doi:
Substances chimiques
Pertussis Vaccine
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
683-686Subventions
Organisme : NIAID NIH HHS
ID : R01 AI101155
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM111274
Pays : United States
Références
Epidemics. 2011 Sep;3(3-4):183-8
pubmed: 22094341
Proc Biol Sci. 2016 Jan 13;283(1822):
pubmed: 26763701
Proc Biol Sci. 2010 Nov 7;277(1698):3239-45
pubmed: 20534609
SIAM J Appl Math. 2014;74(6):1810-1830
pubmed: 25878365
Epidemiol Infect. 2014 Apr;142(4):672-84
pubmed: 23324361
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):E716-7
pubmed: 24516173
Parasitology. 2016 Jun;143(7):835-49
pubmed: 26337864
Sci Transl Med. 2018 Dec 19;10(472):
pubmed: 30567929
Vaccine. 2018 Feb 21;36(9):1160-1166
pubmed: 29395520
J Infect Dis. 1994 Jun;169(6):1297-305
pubmed: 8195607
Science. 2010 Nov 12;330(6006):982-5
pubmed: 21071671
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):787-92
pubmed: 24277828
MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34
pubmed: 16557217
Emerg Infect Dis. 2010 Aug;16(8):1273-8
pubmed: 20678322
Am Nat. 2002 May;159(5):469-81
pubmed: 18707430
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7259-64
pubmed: 21422281
Pediatrics. 2015 Feb;135(2):331-43
pubmed: 25560446
BMC Med. 2016 Sep 01;14(1):121
pubmed: 27580649
JAMA Pediatr. 2016 May 1;170(5):453-8
pubmed: 27018748
N Engl J Med. 2012 Sep 13;367(11):1012-9
pubmed: 22970945
PLoS Comput Biol. 2015 Apr 23;11(4):e1004138
pubmed: 25906150
Vaccine. 2015 Oct 26;33(43):5794-5800
pubmed: 26392008
Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):719-24
pubmed: 25568084
Science. 1999 Oct 29;286(5441):968-71
pubmed: 10542154
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18438-43
pubmed: 17121996
Am J Med Sci. 1951 Sep;222(3):333-61
pubmed: 14877820
Expert Rev Vaccines. 2012 Nov;11(11):1319-29
pubmed: 23249232
Epidemiol Infect. 1988 Jun;100(3):419-42
pubmed: 3378585
PLoS Med. 2013 Oct;10(10):e1001540
pubmed: 24204214